Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
…, J O'shaughnessy, KZ Guyton, DA Mankoff… - Clinical Cancer …, 2005 - AACR
2-[ 18 F]Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique offers a …
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique offers a …
[HTML][HTML] Hyperpolarized 13C MRI: path to clinical translation in oncology
…, KR Keshari, A Kjaer, C Laustsen, DA Mankoff… - Neoplasia, 2019 - Elsevier
This white paper discusses prospects for advancing hyperpolarization technology to better
understand cancer metabolism, identify current obstacles to HP (hyperpolarized) 13 C …
understand cancer metabolism, identify current obstacles to HP (hyperpolarized) 13 C …
ACR appropriateness criteria breast cancer screening
Mammography is the recommended method for breast cancer screening of women in the
general population. However, mammography alone does not perform as well as …
general population. However, mammography alone does not perform as well as …
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
…, AA Lammertsma, S Larson, DA Mankoff… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Despite the increasing use of 18F-FDG PET as a biomarker for predicting therapeutic response,
there are no widely accepted standardized protocols for using 18F-FDG PET as a tool …
there are no widely accepted standardized protocols for using 18F-FDG PET as a tool …
A definition of molecular imaging
DA Mankoff - The Journal of Nuclear Medicine, 2007 - search.proquest.com
To assist with the understanding of molecular imaging in clinical care, statements were
developed that can be used to help communicate the importance of molecular imaging:* …
developed that can be used to help communicate the importance of molecular imaging:* …
Phase II study of daily sunitinib in FDG-PET–positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional …
LL Carr, DA Mankoff, BH Goulart, KD Eaton… - Clinical Cancer …, 2010 - AACR
Purpose: We conducted a phase II study to assess the efficacy of continuous dosing of
sunitinib in patients with flurodeoxyglucose positron emission tomography (FDG-PET)–avid, …
sunitinib in patients with flurodeoxyglucose positron emission tomography (FDG-PET)–avid, …
Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [18F]Fluoromisonidazole and [18F]Fluorodeoxyglucose Positron Emission Tomography …
JG Rajendran, DA Mankoff, F O'Sullivan… - Clinical cancer …, 2004 - AACR
Purpose: The aim of this study is to compare glucose metabolism and hypoxia in four different
tumor types using positron emission tomography (PET). F-labeled fluorodeoxyglucose (…
tumor types using positron emission tomography (PET). F-labeled fluorodeoxyglucose (…
[PDF][PDF] Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
…, EK Schubert, LK Dunnwald, KA Krohn, DA Mankoff - J Clin Oncol, 2006 - academia.edu
Purpose In breast cancer,[18F] fluoroestradiol (FES) positron emission tomography (PET)
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …
Imaging P‐glycoprotein transport activity at the human blood‐brain barrier with positron emission tomography
Background Numerous knockout mouse studies have revealed that P‐glycoprotein (P‐gp)
significantly limits drug distribution across the mouse blood‐brain barrier (BBB). To determine …
significantly limits drug distribution across the mouse blood‐brain barrier (BBB). To determine …
Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer
HA Lehr, DA Mankoff, D Corwin… - … of Histochemistry & …, 1997 - journals.sagepub.com
The benefit of quantifying estrogen receptor (ER) and progesterone receptor (PR) expression
in breast cancer is well established. However, in routine breast cancer diagnosis, receptor …
in breast cancer is well established. However, in routine breast cancer diagnosis, receptor …